Durability of immune responses to SARS-CoV-2 infection and vaccination

MS Suthar - Seminars in Immunology, 2024 - Elsevier
Infection with SARS-CoV-2 in humans has caused a pandemic of unprecedented
dimensions. SARS-CoV-2 is primarily transmitted through respiratory droplets and targets …

Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label …

S Jackson, JL Marshall, A Mawer… - The Lancet …, 2024 - thelancet.com
Summary Background A SARS-CoV-2 controlled human infection model (CHIM) has been
successfully established in seronegative individuals using a dose of 1× 10 1 50% tissue …

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA. 1, BA. 2, BA. 4/5 or Delta associates with similar illness duration …

H Townsley, J Gahir, TW Russell, D Greenwood… - Plos one, 2024 - journals.plos.org
Background SARS-CoV-2 variant Omicron rapidly evolved over 2022, causing three waves
of infection due to sub-variants BA. 1, BA. 2 and BA. 4/5. We sought to characterise …

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA. 1, BA. 2, BA. 5 or Delta associates with similar illness duration, symptom …

H Townsley, J Gahir, TW Russell, EJ Carr, M Dyke… - medRxiv, 2022 - medrxiv.org
Abstract Background SARS-CoV-2 variant Omicron rapidly evolved over 2022, causing
three waves of infection due to sub-variants BA. 1, BA. 2 and BA. 4/5. We sought to …

Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2

EK Roubidoux, PH Brigleb, K Vegesana… - Scientific Reports, 2023 - nature.com
SARS-CoV-2 has caused millions of infections worldwide since its emergence in 2019.
Understanding how infection and vaccination induce mucosal immune responses and how …